BIOVALLEY
About:
BIOVALLEY is a pharmaceutical company that engages in drug development businesses.
Website: http://www.biovalley.cn/
Top Investors: ShenZhen GTJA Investment Group
Description:
Biovalley manufactures and sells the breviscapine series of drugs. They provide injections, capsules, tablets, dripping pills, erigeron capsules, and soft capsules. They provide solutions for ischemic cardiovascular and cerebrovascular diseases, stroke sequelae, and coronary heart disease treatment.
Total Funding Amount:
150M CNY
Headquarters Location:
Kunming, Yunnan, China
Founded Date:
1999-06-13
Founders:
Number of Employees:
11-50
Last Funding Date:
2016-10-12
IPO Status:
Public
Industries:
© 2025 bioDAO.ai